ArticleScientific reports2019

Genome-scale CRISPR activation screen uncovers tumor-intrinsic modulators of CD3 bispecific antibody efficacy.

Corinne E Decker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.